Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • API

    Tag: api

    You Searched For "API"
    Its All In The Name: State drug regulators told to BAN marketing of new formulations in old brand names

    Its All In The Name: State drug regulators told to BAN marketing of new formulations in old brand names

    Farhat Nasim17 May 2019 5:37 PM IST
    New Delhi: In a major setback to many pharma companies in the country, the ruling Government is reported to have directed state drug controllers to...
    Glenmark appoints Yasir Rawjee as CEO of Glenmark Life Sciences

    Glenmark appoints Yasir Rawjee as CEO of Glenmark Life Sciences

    Medical Dialogues Bureau8 May 2019 9:15 AM IST
    Yasir Rawjee joins Glenmark Life Sciences from Mylan, where most recently he was the Head of Global API Operations, Glenmark Pharmaceuticals said in a...
    Alchem solves stability dilemma for micronized DIGOXIN; files PATENT for novel production process

    Alchem solves stability dilemma for micronized DIGOXIN; files PATENT for novel production process

    Meghna A Singhania16 April 2019 4:47 PM IST
    Alchem's molecule is the sole micronized digoxin available globally that resolves the challenge of micro dosage formulation and the long-term...
    Dr Reddys launches B2B Customer Service Portal XCEED

    Dr Reddys launches B2B Customer Service Portal XCEED

    Garima19 March 2019 10:00 AM IST
    Dr Reddys launch of XCEED gives now instant access to an industry-leading portfolio which spans across a wide range of indications and complex...
    Suven Life Sciences enters asset purchase agreement with Rising Pharma

    Suven Life Sciences enters asset purchase agreement with Rising Pharma

    Garima10 March 2019 11:00 AM IST
    Suven Life Sciences through its joint venture partner, Shore Suven Pharma, Inc has entered into a "stalking horse" asset purchase agreement to buy the...
    Hetero Labs recalls over 15.90 lakh bottles of hypertension drug from US

    Hetero Labs recalls over 15.90 lakh bottles of hypertension drug from US

    Ruby Khatun Khatun30 Aug 2018 11:26 AM IST
    New Delhi: Drug firm Hetero Labs is recalling over 15.90 lakh bottles of Valsartan Tablets used for the treatment of hypertension from the American...
    Unichem Labs gets 4 observations from USFDA for Roha facility

    Unichem Labs gets 4 observations from USFDA for Roha facility

    Ruby Khatun Khatun8 Aug 2018 10:30 AM IST
    New Delhi: Drug firm Unichem Laboratories said the US health regulator has made four observations after inspection of its active pharmaceutical...
    Morepen labs gets USFDA approval for 2 bulk drug manufacturing units

    Morepen labs gets USFDA approval for 2 bulk drug manufacturing units

    Ruby Khatun Khatun1 Aug 2018 10:47 AM IST
    New Delhi: Morepen Laboratories Ltd. has received USFDA (United States Food and Drug Administration) approvals for both its bulk drugs manufacturing...
    Dr Reddy

    Dr Reddy's Lab shares gain 3 percent on zero USFDA observations for Srikakulam plant

    Ruby Khatun Khatun5 Jun 2018 10:30 AM IST
    New Delhi: Shares of Dr Reddys Laboratories rose by nearly 3 percent after the company said the USFDA has completed its API Srikakulam plant audit...
    Morepen Labs gets USFDA nod for asthma drug

    Morepen Labs gets USFDA nod for asthma drug

    Ruby Khatun Khatun21 Dec 2017 2:09 PM IST
    New Delhi: Morepen Laboratories said the US health regulator has given approval to Montelukast Sodium, used in managing asthma symptoms and seasonal...
    China accounts for 66 percent of India

    China accounts for 66 percent of India's bulk drug imports in FY'17

    Ruby Khatun Khatun20 Dec 2017 10:15 AM IST
    New Delhi: India's bulk drug imports from top five countries stood at Rs 18,372.54 crore in 2016-17 with China accounting for 66 percent, Parliament...
    Government needs proactive approach to boost pharma sector: Industry

    Government needs proactive approach to boost pharma sector: Industry

    Ruby Khatun Khatun2 Dec 2017 10:15 AM IST
    MUMBAI: Union and state governments need to develop a proactive approach towards building better quality compliance and become a facilitator of funds...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok